Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them

Articles citing Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them

Title / Author	Year
The diagnosis and treatment of prostate cancer: a review MS Litwin, HJ Tan Jama 317 (24), 2532-2542	2017
Bone metastasis: the importance of the neighbourhood PI Croucher, MM McDonald, TJ Martin Nature reviews Cancer 16 (6), 373	2016
Exercise for men with prostate cancer: a systematic review and meta-analysis L Bourke, D Smith, L Steed, R Hooper, A Carter, J Catto, PC Albertsen, ... European urology 69 (4), 693-703	2016
Association of androgen deprivation therapy with depression in localized prostate cancer KT Dinh, G Reznor, V Muralidhar, BA Mahal, MD Nezolosky, TK Choueiri, ... Journal of Clinical Oncology 34 (16), 1905	2016
Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer KM Wadosky, S Koochekpour Oncotarget 7 (39), 64447	2016
Psychological effects of androgen‐deprivation therapy on men with prostate cancer and their partners KA Donovan, LM Walker, RJ Wassersug, LMA Thompson, JW Robinson Cancer 121 (24), 4286-4299	2015
Survivorship and improving quality of life in men with prostate cancer L Bourke, SA Boorjian, A Briganti, L Klotz, L Mucci, MJ Resnick, ... European urology 68 (3), 374-383	2015
Compliance to exercise‐oncology guidelines in prostate cancer survivors and associations with psychological distress, unmet supportive care needs, and quality of life DA Galvão, RU Newton, RA Gardiner, A Girgis, SJ Lepore, A Stiller, ... Psycho‐Oncology 24 (10), 1241-1249	2015
Effects of different exercise modalities on fatigue in prostate cancer patients undergoing androgen deprivation therapy: a year-long randomised controlled trial DR Taaffe, RU Newton, N Spry, D Joseph, SK Chambers, RA Gardiner, ... European Urology 72 (2), 293-299	2017
Survivorship in immune therapy: assessing chronic immune toxicities, health outcomes, and functional status among long-term ipilimumab survivors at a single referral center DB Johnson, DL Friedman, E Berry, I Decker, F Ye, S Zhao, AK Morgans, ... Cancer immunology research 3 (5), 464-469	2015
Cardiovascular effects of androgen deprivation therapy for the treatment of prostate cancer: ABCDE steps to reduce cardiovascular disease in patients with prostate cancer N Bhatia, M Santos, LW Jones, JA Beckman, DF Penson, AK Morgans, ... Circulation 133 (5), 537-541	2016
The effects of resistance exercise on physical performance and health-related quality of life in prostate cancer patients: a systematic review T Hasenoehrl, M Keilani, TS Komanadj, M Mickel, M Margreiter, ... Supportive Care in Cancer 23 (8), 2479-2497	2015
The role of dietary fat throughout the prostate cancer trajectory KM Di Sebastiano, M Mourtzakis Nutrients 6 (12), 6095-6109	2014
Efficacy of recreational football on bone health, body composition, and physical functioning in men with prostate cancer undergoing androgen deprivation therapy: 32-week follow-up of the FC prostate randomised controlled trial J Uth, T Hornstrup, JF Christensen, KB Christensen, NR Jørgensen, ... Osteoporosis International 27 (4), 1507-1518	2016
Long‐term impact of androgen‐deprivation therapy on physical function and quality of life SMH Alibhai, H Breunis, N Timilshina, G Naglie, I Tannock, M Krahn, ... Cancer 121 (14), 2350-2357	2015
Metformin and prostate cancer: a new role for an old drug J Whitburn, CM Edwards, P Sooriakumaran Current urology reports 18 (6), 46	2017
Focal salvage therapy for local prostate cancer recurrences after primary radiotherapy: a comprehensive review DAS Duijzentkunst, M Peters, JRNV van Zyp, MA Moerland, M van Vulpen World journal of urology 34 (11), 1521-1531	2016
Association of black race with prostate cancer–specific and other-cause mortality RT Dess, HE Hartman, BA Mahal, PD Soni, WC Jackson, MR Cooperberg, ... JAMA oncology 5 (7), 975-983	2019
Should docetaxel be standard of care for patients with metastatic hormone-sensitive prostate cancer? Pro and contra K Fizazi, C Jenkins, IF Tannock Annals of Oncology 26 (8), 1660-1667	2015
The complex and multifactorial relationship between testosterone deficiency (TD), obesity and vascular disease AM Traish, M Zitzmann Reviews in Endocrine and Metabolic Disorders 16 (3), 249-268	2015

1 - 20

Dates and citation counts are estimated and are determined automatically by a computer program.